A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

K. Hermansen; M. Davies; T. Derezinski; G. Martinez Ravn; P. Clauson; P. Home;

doi:10.2337/dc05-1365

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

Diabetes Care ◽

10.2337/dc05-1365 ◽

2006 ◽

Vol 29 (6) ◽

pp. 1269-1274 ◽

Cited By ~ 452

Author(s):

K. Hermansen ◽

M. Davies ◽

T. Derezinski ◽

G. Martinez Ravn ◽

P. Clauson ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Detemir ◽

Treat To Target ◽

Oral Glucose ◽

Target Trial ◽

Nph Insulin ◽

Glucose Lowering

Download Full-text

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70010-6 ◽

2007 ◽

Vol 2007 ◽

pp. 12-14

Author(s):

L. Kennedy

Keyword(s):

Type 2 Diabetes ◽

Insulin Detemir ◽

Treat To Target ◽

Oral Glucose ◽

Target Trial ◽

Nph Insulin ◽

Glucose Lowering

Download Full-text

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

Diabetes Care ◽

10.2337/dc09-2294 ◽

2010 ◽

Vol 33 (6) ◽

pp. 1176-1178 ◽

Cited By ~ 101

Author(s):

S. G. Swinnen ◽

M.-P. Dain ◽

R. Aronson ◽

M. Davies ◽

H. C. Gerstein ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Treat To Target ◽

Oral Glucose ◽

Target Trial ◽

Once Daily ◽

Glucose Lowering

Download Full-text

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

Diabetologia ◽

10.1007/s00125-007-0911-x ◽

2008 ◽

Vol 51 (3) ◽

pp. 408-416 ◽

Cited By ~ 305

Author(s):

J. Rosenstock ◽

M. Davies ◽

P. D. Home ◽

J. Larsen ◽

C. Koenen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Treat To Target ◽

Target Trial ◽

Glucose Lowering

Download Full-text

Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center

Primary Care Diabetes ◽

10.1016/j.pcd.2014.01.010 ◽

2014 ◽

Vol 8 (3) ◽

pp. 256-264 ◽

Cited By ~ 2

Author(s):

Soner Cander ◽

Oguzhan Sitki Dizdar ◽

Ozen Oz Gul ◽

Metin Guclu ◽

Oguz Kaan Unal ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Detemir ◽

Treat To Target ◽

Efficacy And Safety ◽

Oral Antidiabetics ◽

Single Center ◽

Target Trial ◽

Daily Insulin ◽

Diabetes Patients

Download Full-text

A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naive patients with Type 2 diabetes

Diabetic Medicine ◽

10.1111/j.1464-5491.2009.02899.x ◽

2010 ◽

Vol 27 (2) ◽

pp. 181-188 ◽

Cited By ~ 31

Author(s):

L. Fogelfeld ◽

M. Dharmalingam ◽

K. Robling ◽

C. Jones ◽

D. Swanson ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Lispro ◽

Insulin Detemir ◽

Treat To Target ◽

Target Trial

Download Full-text

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.12083 ◽

2013 ◽

Vol 15 (8) ◽

pp. 729-736 ◽

Cited By ~ 38

Author(s):

L. Meneghini ◽

J. Kesavadev ◽

M. Demissie ◽

A. Nazeri ◽

P. Hollander

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Insulin Detemir ◽

Treat To Target ◽

Target Trial ◽

Once Daily

Download Full-text

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes

Clinical Therapeutics ◽

10.1016/j.clinthera.2008.11.001 ◽

2008 ◽

Vol 30 (11) ◽

pp. 1976-1987 ◽

Cited By ~ 106

Author(s):

Priscilla Hollander ◽

John Cooper ◽

Jesper Bregnhøj ◽

Claus Bang Pedersen

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Treat To Target ◽

Target Trial ◽

Open Label ◽

Parallel Group ◽

Mealtime Insulin ◽

Basal Bolus

Download Full-text

PDB56 THE IMPACT OF STARTING INSULIN GLARGINE VERSUS INSULIN DETEMIR ON QUALITY OF LIFE (QOL) AND TREATMENT SATISFACTION (TS) IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON ORAL GLUCOSE-LOWERING DRUGS (OGLDS)

Value in Health ◽

10.1016/s1098-3015(10)75034-8 ◽

2009 ◽

Vol 12 (7) ◽

pp. A412

Author(s):

SG Swinnen ◽

T Hajos ◽

F Holleman ◽

MP Dain ◽

JH DeVries ◽

...

Keyword(s):

Quality Of Life ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Satisfaction ◽

Insulin Detemir ◽

Oral Glucose ◽

Glucose Lowering ◽

The Impact

Download Full-text

Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study

Diabetes Therapy ◽

10.1007/s13300-021-01051-9 ◽

2021 ◽

Author(s):

Kristina S. Boye ◽

Maureen J. Lage ◽

Jacek Kiljański

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Oral Glucose ◽

Time To Failure ◽

Glucose Lowering

Download Full-text

PDB3 COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR COMPARED TO NPH INSULIN IN PATIENTS WITH TYPE-2 DIABETES IN THE UNITED KINGDOM

Value in Health ◽

10.1016/s1098-3015(10)65946-3 ◽

2004 ◽

Vol 7 (6) ◽

pp. 735-736

Author(s):

I Smith ◽

AJ Palmer ◽

S Roze ◽

T Kennedy-Martin

Keyword(s):

Type 2 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Detemir ◽

Cost Effectiveness Analysis ◽

Nph Insulin ◽

The United Kingdom ◽

Effectiveness Analysis

Download Full-text